News and Views
Recent Price Movement and Market Comparison
On 09 January, Orchid Pharma’s share price closed at ₹728.00, down ₹29.3 or 3.87% from the previous session. This decline continues a troubling trend, with the stock having lost 8.27% over the past week, significantly underperforming the Sensex benchmark, which declined by only 2.55% during the same period. Over the last month, the stock has fallen 12.72%, while the Sensex dipped a modest 1.29%. Year-to-date, the stock is down 4.10%, compared to the Sensex’s 1.93% decline.
More strikingly, over the last year, Orchid Pharma’s shares have plummeted by 61.68%, in stark contrast to the Sensex’s 7.67% gain. This severe underperformance highlights the market’s growing concerns about the company’s fundamentals and outlook.
